Literature DB >> 23063805

Assessing the invasive potential of bladder cancer: development and validation of a new preclinical assay.

Christian Bolenz1, Christian Gorzelanny, Daniel Knauf, Tanja Keil, Annette Steidler, Natalia Halter, Thomas Martini, Stefan W Schneider.   

Abstract

PURPOSE: We developed and validated an electrophysiological method for standardized preclinical assessment of the invasive potential of urothelial carcinoma of the bladder.
MATERIALS AND METHODS: Human UMUC-3, RT-112, HT-1197 and T24/83 bladder urothelial carcinoma cells, and UROtsa benign urothelial cells were co-cultivated with high resistance MDCK-C7 cells seeded below a 0.4 μm pore membrane of an insert to avoid physical contact and cellular migration. Transepithelial electrical resistance in Ω cm(2) across the MDCK-C7 monolayer was measured longitudinally. Invasive potential coefficients were calculated based on the secretion of proteolytic factors by invading cells.
RESULTS: Consistent transepithelial electrical resistance breakdown patterns were reproduced in 14 or more independent samples of each cell line. Coefficients of invasive potential were significantly higher in bladder urothelial carcinoma than UROtsa cells, including a mean ± SD of 1.5 ± 0.32 vs 9.9 ± 4.97 in UMUC-3, 12.5 ± 6.61 in T24/83, 20.5 ± 4.24 in RT-112 and 21.0 ± 5.15 in HT-1197 cells (p <0.001). No correlation was found between the secretion patterns of matrix metalloproteinase-1, 2 and 9, and invasive potential. Stimulation of UROtsa cells with recombinant human epidermal growth factor up-regulated matrix metalloproteinase-9 secretion and significantly increased invasive potential a mean of 1.3 ± 0.22 vs 14.6 ± 3.28 after stimulation with 10 ng/ml epidermal growth factor (p <0.001).
CONCLUSIONS: We developed a highly sensitive translational tool to study the initial process of metastatic spread of urothelial carcinoma of the bladder. The presented electrophysiological invasion assay enables reliable quantification of the invasive potential of bladder urothelial carcinoma cells before physical transmigration. It can be used to identify key molecules for bladder urothelial carcinoma invasion and develop new therapeutic strategies.
Copyright © 2013 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23063805     DOI: 10.1016/j.juro.2012.10.007

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  3 in total

Review 1.  [Invasion patterns and metastasis of urothelial carcinoma. A challenge for translational research].

Authors:  C Bolenz; T Martini; M S Michel
Journal:  Urologe A       Date:  2013-09       Impact factor: 0.639

2.  Decreased Invasion of Urothelial Carcinoma of the Bladder by Inhibition of Matrix-Metalloproteinase 7.

Authors:  Christian Bolenz; Daniel Knauf; Axel John; Philipp Erben; Annette Steidler; Stefan W Schneider; Cagatay Günes; Christian Gorzelanny
Journal:  Bladder Cancer       Date:  2018-01-20

3.  The Role of Interleukin-1-Receptor-Antagonist in Bladder Cancer Cell Migration and Invasion.

Authors:  Lisa Schneider; Junnan Liu; Cheng Zhang; Anca Azoitei; Sabine Meessen; Xi Zheng; Catharina Cremer; Christian Gorzelanny; Sybille Kempe-Gonzales; Cornelia Brunner; Felix Wezel; Christian Bolenz; Cagatay Gunes; Axel John
Journal:  Int J Mol Sci       Date:  2021-05-30       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.